James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Aetna Uncertainty Is Keeping CVS Stock Way Undervalued

It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.

Next-Gen Xbox Won’t Launch Microsoft Stock, But It Doesn’t Need To

There's little doubt the development surrounds MSFT stock with a bullish buzz, but video games aren't that big of a business for Microsoft.

Pricing Changes Could Hurt CSX Stock

If you own or are mulling a position in CSX stock, take note of the legislative changes that have been recently proposed.

3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics

Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.

The Problem Is, GE Stock Is Just Unknowable Right Now

Treat GE stock like a normal pick at your own peril, and take analyst views of General Electric with a grain of salt.